Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16751396rdf:typepubmed:Citationlld:pubmed
pubmed-article:16751396lifeskim:mentionsumls-concept:C0214743lld:lifeskim
pubmed-article:16751396lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:16751396lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:16751396lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:16751396lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:16751396lifeskim:mentionsumls-concept:C1149190lld:lifeskim
pubmed-article:16751396lifeskim:mentionsumls-concept:C1416386lld:lifeskim
pubmed-article:16751396lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:16751396lifeskim:mentionsumls-concept:C1979845lld:lifeskim
pubmed-article:16751396lifeskim:mentionsumls-concept:C1704711lld:lifeskim
pubmed-article:16751396lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:16751396lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:16751396pubmed:issue12lld:pubmed
pubmed-article:16751396pubmed:dateCreated2006-6-5lld:pubmed
pubmed-article:16751396pubmed:abstractTextIL-13, a critical cytokine for allergic inflammation, exerts its effects through a complex receptor system including IL-4Ralpha, IL-13Ralpha1, and IL-13Ralpha2. IL-4Ralpha and IL-13Ralpha1 form a heterodimeric signaling receptor for IL-13. In contrast, IL-13Ralpha2 binds IL-13 with high affinity but does not signal. IL-13Ralpha2 exists on the cell surface, intracellularly, and in soluble form, but no information is available regarding the relative distributions of IL-13Ralpha2 among these compartments, whether the compartments communicate, and how the relative expression levels impact IL-13 responses. Herein, we investigated the distribution of IL-13Ralpha2 in transfected and primary cells, and we evaluated how the total level of IL-13Ralpha2 expression impacted its distribution. Our results demonstrate that the distribution of IL-13Ralpha2 is independent of the overall level of expression. The majority of the IL-13Ralpha2 protein existed in intracellular pools. Surface IL-13Ralpha2 was continually released into the medium in a soluble form, yet surface expression remained constant supporting receptor trafficking to the cell surface. IL-13Ralpha2 inhibited IL-13 signaling proportionally to its level of expression, and this inhibition could be overcome with high concentrations of IL-13.lld:pubmed
pubmed-article:16751396pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16751396pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16751396pubmed:languageenglld:pubmed
pubmed-article:16751396pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16751396pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16751396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16751396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16751396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16751396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16751396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16751396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16751396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16751396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16751396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16751396pubmed:statusMEDLINElld:pubmed
pubmed-article:16751396pubmed:monthJunlld:pubmed
pubmed-article:16751396pubmed:issn0022-1767lld:pubmed
pubmed-article:16751396pubmed:authorpubmed-author:DainesMichael...lld:pubmed
pubmed-article:16751396pubmed:authorpubmed-author:HersheyGurjit...lld:pubmed
pubmed-article:16751396pubmed:authorpubmed-author:TabataYasuhir...lld:pubmed
pubmed-article:16751396pubmed:authorpubmed-author:ChenWeiguoWlld:pubmed
pubmed-article:16751396pubmed:authorpubmed-author:BasuSaswataSlld:pubmed
pubmed-article:16751396pubmed:authorpubmed-author:WarrierManoj...lld:pubmed
pubmed-article:16751396pubmed:authorpubmed-author:WalkerBradley...lld:pubmed
pubmed-article:16751396pubmed:issnTypePrintlld:pubmed
pubmed-article:16751396pubmed:day15lld:pubmed
pubmed-article:16751396pubmed:volume176lld:pubmed
pubmed-article:16751396pubmed:ownerNLMlld:pubmed
pubmed-article:16751396pubmed:authorsCompleteYlld:pubmed
pubmed-article:16751396pubmed:pagination7495-501lld:pubmed
pubmed-article:16751396pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:meshHeadingpubmed-meshheading:16751396...lld:pubmed
pubmed-article:16751396pubmed:year2006lld:pubmed
pubmed-article:16751396pubmed:articleTitleLevel of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling.lld:pubmed
pubmed-article:16751396pubmed:affiliationDivision of Allergy and Immunology, Department of Pediatrics, Cincinnati Children' Hospital Medical Center, OH 45229, USAlld:pubmed
pubmed-article:16751396pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16751396pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:16751396pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:3598entrezgene:pubmedpubmed-article:16751396lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16751396lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16751396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16751396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16751396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16751396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16751396lld:pubmed